MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

PHR.US

25.33

-0.94%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

PHR.US

25.33

-0.94%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

PHR.US

25.33

-0.94%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

PHR.US

25.33

-0.94%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

PHR.US

25.33

-0.94%↓

Search

Agilent Technologies Inc

Închisă

SectorSănătate

113.65 -2.76

Rezumat

Modificarea prețului

24h

Curent

Minim

113.31

Maxim

116.76

Indicatori cheie

By Trading Economics

Venit

-33M

318M

Vânzări

-20M

1.7B

P/E

Medie Sector

27.975

73.239

EPS

1.31

Randament dividend

0.82

Marjă de profit

18.917

Angajați

17,900

EBITDA

59M

467M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+30.94% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.82%

3.06%

Următoarele câștiguri

28 mai 2025

Data viitoare de dividende

23 apr. 2025

Următoarea dată ex-dividende

1 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-8.5B

35B

Deschiderea anterioară

116.41

Închiderea anterioară

113.65

Sentimentul știrilor

By Acuity

23%

77%

47 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Agilent Technologies Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 aug. 2024, 09:29 UTC

Câștiguri

UBS Net Profit Beats Expectations on Credit Suisse Savings -- 3rd Update

14 ian. 2025, 13:05 UTC

Achiziții, Fuziuni, Preluări

Topicus.com in Agreement to Acquire Cipal Schaubroeck in Belgium >

30 mai 2024, 18:36 UTC

Câștiguri

These Stocks Are Moving the Most Today: Salesforce, UiPath, HP Inc., Best Buy, Kohl's, Foot Locker, C3.ai, Nutanix, and More -- Barrons.com

Comparație

Modificare preț

Agilent Technologies Inc Așteptări

Obiectiv de preț

By TipRanks

30.94% sus

Prognoză pe 12 luni

Medie 153.17 USD  30.94%

Maxim 160 USD

Minim 138 USD

În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAgilent Technologies Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

9 ratings

6

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

116.36 / 119.6898Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

47 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.